HemaCare Co. (OTCMKTS:HEMA – Get Free Report)’s stock price was up 0.6% during trading on Wednesday . The company traded as high as $25.31 and last traded at $25.31. Approximately 5,400 shares changed hands during mid-day trading, a decline of 86% from the average daily volume of 39,950 shares. The stock had previously closed at $25.16.
HemaCare Price Performance
The company has a 50-day moving average of $25.31 and a 200 day moving average of $25.31.
About HemaCare
HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy.
Featured Stories
- Five stocks we like better than HemaCare
- ESG Stocks, What Investors Should Know
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- 3 Tickers Leading a Meme Stock Revival
- 2 Drone Stocks Surging from Increased Media Attention
- Bank Stocks – Best Bank Stocks to Invest In
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for HemaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HemaCare and related companies with MarketBeat.com's FREE daily email newsletter.
